Dietary fatty acids and lipoprotein metabolism: new insights and updates

Purpose of review Dyslipidemia is a powerful risk factor for cardiovascular disease (CVD). Dietary fatty acid composition regulates lipids and lipoprotein metabolism and may confer CVD benefit. This review updates understanding of the effect of dietary fatty acids on lipoprotein metabolism in humans. Recent findings High dietary fish-derived n-3 polyunsaturated fatty acid (PUFA) consumption diminished hepatic triglyceride-rich lipoprotein (TRL) secretion and enhanced TRL to LDL conversion. n-3 PUFA also decreased TRL-apoB-48 concentration by decreasing TRL-apoB-48 secretion. High n-6 PUFA intake decreased liver fat, and plasma proprotein convertase subtilisin/kexin type 9, triglycerides, total-cholesterol and LDL-cholesterol concentrations. Intake of saturated fatty acids with increased palmitic acid at the sn-2 position was associated with decreased postprandial lipemia, which might be due to decreased triglyceride absorption. Replacing carbohydrate with monounsaturated fatty acids increased TRL catabolism. Ruminant trans-fatty acid decreased HDL cholesterol, but the mechanisms are unknown. A new role for APOE genotype in regulating lipid responses was also described. Summary The major advances in understanding the effect of dietary fatty acids on lipoprotein metabolism have focused on n-3 PUFA. This knowledge provides insights into the importance of regulating lipoprotein metabolism as a mode to improve plasma lipids and potential CVD risk. Further studies are required to better understand the cardiometabolic effects of other dietary fatty acids.

[1]  D. Ferrante,et al.  Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. , 2013, Journal of the American College of Cardiology.

[2]  Julie A Lovegrove,et al.  APOE genotype influences triglyceride and C-reactive protein responses to altered dietary fat intake in UK adults. , 2012, The American journal of clinical nutrition.

[3]  A. Minihane,et al.  Dietary fat manipulation has a greater impact on postprandial lipid metabolism than the apolipoprotein E (epsilon) genotype-insights from the SATgenε study. , 2012, Molecular nutrition & food research.

[4]  D. Mozaffarian,et al.  Fish oil and postoperative atrial fibrillation: The omega-3 fatty acids for prevention of post-operative atrial fibrillation (OPERA) randomized trial , 2012 .

[5]  H. Rasmussen,et al.  Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects , 2012, Journal of Lipid Research.

[6]  S. Yusuf,et al.  n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. , 2012, The New England journal of medicine.

[7]  E. Riboli,et al.  Plasma Phospholipid Fatty Acid Concentration and Incident Coronary Heart Disease in Men and Women: The EPIC-Norfolk Prospective Study , 2012, PLoS medicine.

[8]  M. Uusitupa,et al.  Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. , 2012, The American journal of clinical nutrition.

[9]  P. Paquin,et al.  Randomized controlled study of the effect of a butter naturally enriched in trans fatty acids on blood lipids in healthy women , 2011, The American journal of clinical nutrition.

[10]  T. Sanders,et al.  Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. , 2011, The American journal of clinical nutrition.

[11]  D. Mozaffarian,et al.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.

[12]  E. Fisher,et al.  Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy , 2011, Journal of Lipid Research.

[13]  J. Chardigny,et al.  Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. , 2011, Advances in nutrition.

[14]  B. Nordestgaard,et al.  Methods to study postprandial lipemia. , 2011, Current vascular pharmacology.

[15]  J. Geleijnse,et al.  n-3 fatty acids and cardiovascular events after myocardial infarction. , 2010, The New England journal of medicine.

[16]  F. Sacks,et al.  Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III. , 2008, The American journal of clinical nutrition.

[17]  R. Eckel,et al.  Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. , 2007, Circulation.

[18]  P Hugh R Barrett,et al.  Thematic review series: Patient-Oriented Research. Design and analysis of lipoprotein tracer kinetics studies in humans Published, JLR Papers in Press, May 25, 2006. , 2006, Journal of Lipid Research.

[19]  R. Eckel,et al.  Dietary Hydrogenated Fat Increases High-Density Lipoprotein apoA-I Catabolism and Decreases Low-Density Lipoprotein apoB-100 Catabolism in Hypercholesterolemic Women , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[20]  B Meier,et al.  Repeat coronary angioplasty. , 1984, Journal of the American College of Cardiology.

[21]  N. Le,et al.  Effect of changing dietary fat saturation on low-density lipoprotein metabolism in man. , 1981, The American journal of physiology.

[22]  D. Mozaffarian,et al.  Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. , 2012, JAMA.

[23]  S. Grundy,et al.  Effects of Saturated and Polyunsaturated Fat Diets on the Chemical Composition and Metabolism of Low Density Lipoproteins in Man , 2022 .